The ESG Advantage
Forging resilience and value at RPG Life Sciences
- Domain
- Sustainable Finance
- Kind
- Independent research
- Length
- 14 pp · 15 MB
What it found
- +707%
- share performance against peers
- ₹5.65 Cr
- annual carbon-tax exposure quantified

Overview
An ESG value case on a listed Indian pharma compounding +707% against peers while macro carbon pressure rises: quantifies a ₹5.65 Cr annual carbon-tax exposure, maps strategic materiality, and frames how to decouple financial performance from environmental impact.